A groundbreaking study suggests that intermittent fasting could be more effective than standard diabetes medications for managing Type 2 diabetes. Participants who followed a 5:2 intermittent fasting diet—eating normally for five days and drastically reducing calories for two—showed significant improvements in blood sugar levels and substantial weight loss compared to
Jennifer Hyman of Rent the Runway and Deirdre Quinn of Lafayette 148 discussed with the Wall Street Journal how Ozempic users are reshaping fashion trends and boosting apparel sales. Ozempic and/or Mounjaro users are likely to sustain their weight loss if they can stay away from processed meals and obtain
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
Scientists have found an easy way to lose weight. While the study’s goal was not to identify strategies to reduce weight, the data demonstrate that improving and sustaining improved sleep patterns can have a major impact.